A 68-year-old woman is evaluated in the hospital for a deep vein thrombosis of the left lower extremity. She is prescribed oral warfarin. However, a bridging parenteral anticoagulant is not initiated. Three days later, the patient develops painful, well-demarcated, erythematous lesions on her abdomen and breasts that rapidly progress to purpuric necrosis and eschar formation. This patient's dermatologic complication is most directly caused by a precipitous decline in the plasma activity of which of the following?
- Protein CAnswer
- BAntithrombin
- CFactor II
- DFactor VIII
- EPlatelets
Answer
Protein C
The correct answer is Protein C. Warfarin acts by inhibiting the enzyme vitamin K epoxide reductase, which prevents the gamma-carboxylation and activation of vitamin K-dependent clotting factors (II, VII, IX, and X) as well as the endogenous anticoagulant proteins C and S. Because Protein C has a much shorter half-life (approximately 8 hours) compared to the procoagulant factors like Factor II (approximately 60 hours), initiating warfarin without a bridging anticoagulant causes a transient, severe depletion of Protein C while procoagulant factors remain circulating. This imbalance creates a paradoxical hypercoagulable state, leading to microvascular thrombosis and the classic presentation of warfarin-induced skin necrosis.
Step-by-Step Solution
Key Concept
Warfarin-induced skin necrosis due to early depletion of Protein C.